BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Brzdęk M, Zarębska-Michaluk D, Rzymski P, Lorenc B, Kazek A, Tudrujek-Zdunek M, Janocha-Litwin J, Mazur W, Dybowska D, Berak H, Parfieniuk-Kowerda A, Klapaczyński J, Sitko M, Sobala-Szczygieł B, Piekarska A, Flisiak R. Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era. World J Gastroenterol 2023; 29(13): 2015-2033 [PMID: 37155527 DOI: 10.3748/wjg.v29.i13.2015]
URL: https://www.wjgnet.com/1007-9327/full/v29/i13/2015.htm
Number Citing Articles
1
Nadiia Kasianchuk, Krystyna Dobrowolska, Sofiia Harkava, Andreea Bretcan, Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Robert Flisiak, Piotr Rzymski. Gene-Editing and RNA Interference in Treating Hepatitis B: A ReviewViruses 2023; 15(12): 2395 doi: 10.3390/v15122395
2
Emma Warren, Belinda J. C. Castles, Gillian C. Sharratt, Aitor Arteaga. Direct-Acting Antivirals Remain Cost-Effective Treatments for Chronic Hepatitis C in Australia Despite Changes to the Treated Population and the Availability of Retreatment: The Glecaprevir/Pibrentasvir (Maviret®) ExampleInfectious Diseases and Therapy 2024; 13(3): 549 doi: 10.1007/s40121-024-00926-1
3
Dorota Dybowska, Dorota Zarębska-Michaluk, Piotr Rzymski, Hanna Berak, Beata Lorenc, Marek Sitko, Michał Dybowski, Włodzimierz Mazur, Magdalena Tudrujek-Zdunek, Justyna Janocha-Litwin, Ewa Janczewska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Anna Piekarska, Barbara Sobala-Szczygieł, Krystyna Dobrowolska, Malgorzata Pawłowska, Robert Flisiak. Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disordersWorld Journal of Gastroenterology 2023; 29(25): 4085-4098 doi: 10.3748/wjg.v29.i25.4085